{"organizations": [], "uuid": "31c7bee9167bb557d964cfdaac820318b6b5de05", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 7, "shares": 7, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-11820/social", "site_section": "https://www.wsj.com/europe", "section_title": "The Wall Street Journal &amp; Breaking News, Business, Financial and Economic News, World News and Video", "url": "https://www.wsj.com/articles/celgenes-buybacks-are-coming-up-empty-1527175435", "country": "US", "domain_rank": 387, "title": "Celgene’s Buybacks Are Coming Up Empty", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-24T19:23:00.000+03:00", "replies_count": 0, "uuid": "31c7bee9167bb557d964cfdaac820318b6b5de05"}, "author": "Charley Grant", "url": "https://www.wsj.com/articles/celgenes-buybacks-are-coming-up-empty-1527175435", "ord_in_thread": 0, "title": "Celgene’s Buybacks Are Coming Up Empty", "locations": [], "entities": {"persons": [{"name": "thu", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "celgene", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Celgene is opening its wallet yet again, but to what end?\nThe struggling biotech giant announced Thursday that it plans to spend $2 billion on an accelerated stock repurchase. That is about 4% of the company’s market value as of Wednesday’s closing price.\nCelgene’s shares rose early Thursday as they typically do after such announcements,... ", "external_links": [], "published": "2018-05-24T19:23:00.000+03:00", "crawled": "2018-05-25T05:22:12.000+03:00", "highlightTitle": ""}